PRQR
#3528
ProQR Therapeutics N.V. - Ordinary Shares
2.1 2 USD
0.00%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-0.47%
Changement Mensuel
+22.54%
Evolution sur 6 mois
+38.56%
Changement Annuel
-6.61%
Clôture Précédente
2.1 3
Open
2.1 2
Low
2.1 2
High
2.1 2
Volume
25
Financials
- Market Capitalization 223.37 M
- Employee 187
- Founded 2012
- CEO Daniel A. de Boer
- Website www.proqr.com
- Headquarter Netherlands
- FIGI UNKNOWN
- Industry Biotechnologies
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3491 |  RNA Atrium Therapeutics, Inc. - Common Stock | 13.77 USD | +3.38% | -1.15% | +20.26% | -80.42% | 235.54 M USD | ||
| 3505 |  TARA Protara Therapeutics, Inc. - Common Stock | 3.90 USD | +1.04% | -2.50% | -1.02% | +23.03% | 230.47 M USD | ||
| 3541 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 15.01 USD | +0.40% | -19.30% | +11.19% | +29.40% | 220.32 M USD | ||
| 3546 |  KROS Keros Therapeutics, Inc. - common stock | 11.07 USD | -0.09% | -5.06% | +8.96% | -26.69% | 219.49 M USD |